Document |
Document Title |
WO/1997/007096A1 |
The invention concerns novel alkoxyacrylic acid thiol esters of formula (I) in which Ar, G, R1, R2 and Z have the meanings given in the description. The invention further concerns a method for their preparation, their use as fungicides, ...
|
WO/1997/006133A1 |
Hydroximic acid derivatives have the formula (I), in which the substituents have the following meanings: X stands for CH, CHO or NO; Y stands for O or NH; Z stands for O, S or NRa; Ra stands for hydrogen, alkyl, alkenyl or alkinyl; R1 st...
|
WO/1997/003948A1 |
2-Substituted benzohydroximoyl derivatives represented by general formula (I), an intermediate for the production of the same and a pesticide or bactericide comprising the same as the active ingredient, wherein R1 represents CHO or CH2OR...
|
WO/1997/001530A1 |
Oxime ethers of formula (I) in which a) X is an N atom and Y is an oxygen atom or NH, or b) X is CH and Y is an oxygen atom, in which furthermore R1 is C1-C4alkyl; R2 is hydrogen, C1-C4alkyl or cyclopropyl; and in which R3 and R4 are as ...
|
WO/1997/000859A1 |
Thioamide S-oxides of formula (I) are suitable as fungicidally, insecticidally and acaricidally active ingredients in crop protection, in which R1 is hydrogen or C1-C4alkyl, and R2 is hydrogen, C1-C4alkyl, C2-C4alkenyl, C2-C4alkynyl or C...
|
WO/1996/041869A1 |
The soporific activity of cis-9,10-octadecenoamide and other soporific fatty acid primary amides is neutralized by hydrolysis in the presence of cis-9,10-octadecenoamidase. Hydrolysis of cis-9,10-octadecenoamide leads to the formation of...
|
WO/1996/040672A1 |
Combinatorial libraries are constructed to include aminodiol monomer subunits connected by phosphodiester, phosphorothioate, or phosphoramidate linking moieties. Combinatorial libraries of the invention feature a plurality of functional ...
|
WO/1996/040694A1 |
The present invention describes carbonothiate phospholiped analogs which are novel substrates of phospholipases, lysophosphilipases and lipases. Also described is a process for producing the substrate, detecting phospholipase A2, measuri...
|
WO/1996/039382A1 |
A compound of formula (I) wherein R1 is cyano, thiocarbamoyl, a group of formula (a) in which R4 is hydrogen, lower alkyl which may have optionally substituted aryl, acyl, optionally substituted aryl, lower alkylthio or 1-lower alkylindo...
|
WO/1996/034851A1 |
The present invention provides a compound of formula (I), (II), (III) or (IV), processes for the preparation of the compounds of the invention, intermediates useful in these processes, a pharmaceutical composition, and methods of using t...
|
WO/1996/034850A1 |
The present invention provides a compound of formula (I) processes for the preparation of the compounds of the invention, intermediates useful in these processes, a pharmaceutical composition, and methods of using the compounds of the in...
|
WO/1996/033179A1 |
The present invention features compounds and methods for inhibiting hyper-proliferative cell growth. The compounds and method are preferably used to treat patients having a hyper-proliferative cell disorder. The compounds are preferably ...
|
WO/1996/033164A1 |
Hydroximic acid derivatives of general formula (I), wherein G is either G1 or G2 or G3 or G4 of the formula: R5OC=C(COOR4)-, R5ON=C(COOR4)-, R5ON=C(CONR6R7)-, R5OC=C(CONR6R7)-, X1, X2, X3 are H, halo, HO, mercapto, nitro, SCN, azido, CN,...
|
WO/1996/032946A1 |
Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising: (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii...
|
WO/1996/031496A1 |
The present invention is directed to methadone derivatives which are synthesized for the covalent attachment to antigens (proteins or polypeptides) for the preparation of antibodies or receptors to methadone and methadone metabolites. Th...
|
WO/1996/030329A1 |
The invention relates to substituted benzenes and derivatives thereof, useful as neuraminidase inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these compounds for treating viral and other inf...
|
WO/1996/030395A2 |
A pharmaceutical composition for inhibiting cysteine protease which comprises a compound of formula (I), wherein R1 is a hydrogen atom or an acyl group; R2, R3 and R4, same or different, are a bond, an amino acid residue or a group of th...
|
WO/1996/027585A1 |
Novel amino acid derivatives having an N,N-dialkylaminophenyl group represented by general formula (I), wherein R1 represents hydrogen, lower alkyl, phenyl lower alkyl, lower alkanoyl or benzoyl, provided that the phenyl ring in the phen...
|
WO/1996/026185A1 |
A reagent comprising a compound of formula (I): Rf-M(X)(Z)n-Y-R, wherein R is a hydrocarbon radical advantageously having at most 10 carbon atoms and being selected from alkyls and aryls; Rf is a radical of formula (II): R1-(C'XI'2)m-CF2...
|
WO/1996/022998A1 |
Compounds of formula (I) wherein R, R1, R2, R3, R4, m and n have the meanings reported in the description, processes for their preparation and pharmaceutical compositions which contain them as active ingredients are described. The compou...
|
WO/1996/022987A1 |
The present invention provides a novel process for the preparation of 1,1-cyclopropanedimethanonl cyclic sulfite which comprises: (a) contacting 1,1-cyclopropanedimethanol with dialkylsulfite in the presence of a base; and (b) removing f...
|
WO/1996/020930A1 |
Acetylenes substituted with a phenyl or heteroaryl group and with a 5,6,7,8-tetrahydronaphthyl or 7,8-dihydronaphthyl group have retinoid-like biological activity. The 5,6,7,8-tetrahydronaphthyl or 7,8-dihydronaphthyl group is substitute...
|
WO/1996/019446A1 |
'beta'-Carboxy sulfonyl compounds of formula (I), wherein R1 is aryl, R3 is hydrogen or alkyl, R3 and R4 are hydrogen or alkyl, Y is -O-, -S-, or -NR2-, and R5 is alkyl or aryl are potent inhibitors of the enzyme acyl CoA:cholesterol acy...
|
WO/1996/018372A2 |
Novel cationic amphiphiles are provided that facilitate transport of biologically active (therapeutic) molecules into cells. The amphiphiles contain lipophilic groups derived from steroids, from mono or dialkylamines, or from alkyl or ac...
|
WO/1996/018644A1 |
The present invention discloses peptide aldehydes of formula (I) which are potent and specific inhibitors of thrombin, their pharmaceutically acceptable salts, pharmaceutically acceptable compositions thereof, and methods of using them a...
|
WO/1996/017840A1 |
Compounds of formula (I) wherein Q is optionally substituted heterocyclyl; Z is optionally substituted hydroxy or mercapto; E is (i) CO--N(R2), (ii) CS--N(R2) or (iii) C(SR2) = N; W is O, N(R3), optionally substituted methylene or ethyle...
|
WO/1996/016030A1 |
Iminooxymethylene anilides have the formula (I), in which the substituents and indices have the following meanings: R stands for hydrogen, optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, cycloalkinyl, alkylcarbo...
|
WO/1996/016027A1 |
Compounds of formula (I) and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviate...
|
WO/1996/016020A1 |
The present invention relates to a method of synthesizing a 2-substituted nitrogen containing compound having formula (I), by reacting a hydroxylamine of formula (II); or a nitrone of formula (III); with a compound of formula (IV); there...
|
WO/1996/016026A1 |
Compounds of formula (I), wherein Y is hydrogen, C1-C4alkyl, C1-C4alkoxy, OH, CN, NO2, Si(CH3)3, CF3 or halogen, and T is a group (a) or (b), and wherein the remaining substituents have the following definitions: X is O, S or NR13; A is ...
|
WO/1996/015096A1 |
Inhibitors for matrix metalloproteases, pharmaceutical compositions containing them, and a process for using them to treat a variety of physiological conditions. The compounds of the invention have the generalized formula (T)xA-B-D-E-G, ...
|
WO/1996/015092A1 |
Fluorine-containing liquid crystal compounds comprise a fluorocarbon terminal portion having at least one catenary ether oxygen and a hydrocarbon terminal portion, the terminal portions being connected by a central core. The compounds ha...
|
WO/1996/013509A1 |
Fluorinated alkene compounds having structure (I) wherein Q is -(C=S)-R1, -(C=W)-R2, or -(P=W)R3R4; wherein W is O or S; and R1 to R4 are as defined in claim 1; are useful for controlling nematodes, insects, and acarids that prey on agri...
|
WO/1996/011188A1 |
New sulfonylaminocarbonyltriazolinones with substituents bound by oxygen and sulphur have the formula (I), in which n equals 0, 1 or 2; R1 stands for hydrogen or an optionally substituted rest from the group alkyl, alkenyl, alkinyl, cycl...
|
WO/1996/008483A1 |
Products of formula (ID), in which R1 is hydrogen, carboxy, formyl, alkyl, hydroxyalkyl, alkoxyalkyl, carbamoyl, N-alkyl-carbamoyl, NNdialkylcarbamoyl, alkoxycarbothioate or alkylcarbonyl, V1 is oxygen or -NH-, V2 is -V1H or hydrogen and...
|
WO/1996/007652A1 |
Synthetic calicheamicin mimics employ alternative activation triggers and trigger sites and include tethers for conjugation to DNA targeting systems.
|
WO/1996/007633A1 |
The invention pertains to phenylacetic acid alkyl esters of formula I, wherein the index and substituents are as follows: R' is formyl, alkyl carbonyl or alkyl; R'' is alkyl; U is -O-, -S-, -NH- or -NHO-; V is -O-, -S-, or -NH-; X is cya...
|
WO/1996/007636A1 |
The invention pertains to new imidic acid derivatives of formula (I), methods for preparing them and their use as pesticides.
|
WO/1996/006072A1 |
Compounds of formula (I) are suitable for controlling and preventing infestation by micro-organisms, insects and acarina on plants and their possible isomers and mixtures of isomers, wherein (a) X is CH2F or CHF2, Y is CH and Z is OCH3, ...
|
WO/1996/004239A1 |
New N-alkoxy-amidine derivatives having the formula (I) are disclosed, as well as a process for preparing the same and their use as pesticides. Also disclosed are new intermediate products and a process for preparing the same.
|
WO/1996/003120A1 |
A class of novel indene-1-functional compounds is disclosed together with the use of such indene compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of conditions such as septic shock. The compounds are indene-1-...
|
WO/1996/002500A1 |
The invention relates to novel chelate formers containing sulphonamide groups and their metallic chelates of general formula (I) in which n, m, p, V1, V2, V3, V4, X1, X2, X3, R1, R2, R3 and R4 have different meanings, pharmaceutical agen...
|
WO/1995/035284A1 |
Compounds of general formula (1) are described wherein =W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m-[where m is zero or an integer of value 1 or 2], or -N(Rb)- where Rb is a hydrogen atom ...
|
WO/1995/035281A1 |
Compounds of general formula (1) are described, wherein = W- is (1) =C(Y)- where Y is a halogen atom, or an alkyl or -XRa group where X is -O-, -S(O)m- [where m is zero or an integer of value 1 or 2], or -N(Rb)- [where Rb is a hydrogen a...
|
WO/1995/034536A1 |
A group of 2-amino-3-aroyl-benzo['beta']thiophenes are prepared by preparing an 'alpha'-hydroxy thioacetamide by silyl mediated condensation of an aldehyde with an anion of dialkylamino thioformamide, cyclizing the 'alpha'-hydroxy thioam...
|
WO/1995/034534A1 |
A compound of formula (I), wherein R1 is a C1-6 straight or branched chain alkyl group, a C2-6alkenyl group, a C2-6alkynyl group, a C3-6cycloalkyl group or a C3-6cycloalkyl C1-6alkyl group, each optionally substituted by one to three gro...
|
WO/1995/033710A1 |
Disclosed are carbamoyl carboxylic acid hydrazides (I) and their salts, wherein: R1 is optionally substitued alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, aryl or heteroaryl or an optionally substituted non-aromatic carbo- or hetero...
|
WO/1995/032185A1 |
HIV protease inhibitors of formula (1), in which Q1 to Q8, E, and Y are as defined in Claim 1, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV viru...
|
WO/1995/032184A1 |
Aminimide- and oxazolone-based molecules, and arrays thereof, having at least two structural diversity elements are made via systematic modular production. A combinatorial library of aminimide- and oxazolone-based molecules is made via s...
|
WO/1995/029899A1 |
The invention concerns compounds of formula (I) and their salts, W1, W2, R, n, R1, R2, R4, X, Y and Z being defined as in claim 1 and R3 meaning an acyl residue. These compounds are suitable as herbicides and plant-growth regulators. The...
|